149 related articles for article (PubMed ID: 8584452)
1. RRR-alpha-tocopheryl succinate inhibits the proliferation of human prostatic tumor cells with defective cell cycle/differentiation pathways.
Israel K; Sanders BG; Kline K
Nutr Cancer; 1995; 24(2):161-9. PubMed ID: 8584452
[TBL] [Abstract][Full Text] [Related]
2. RRR-alpha-tocopheryl succinate inhibits DNA synthesis and enhances the production and secretion of biologically active transforming growth factor-beta by avian retrovirus-transformed lymphoid cells.
Simmons-Menchaca M; Qian M; Yu W; Sanders BG; Kline K
Nutr Cancer; 1995; 24(2):171-85. PubMed ID: 8584453
[TBL] [Abstract][Full Text] [Related]
3. RRR-alpha-tocopheryl succinate induction of DNA synthesis arrest of human MDA-MB-435 cells involves TGF-beta-independent activation of p21Waf1/Cip1.
Yu W; Sanders BG; Kline K
Nutr Cancer; 2002; 43(2):227-36. PubMed ID: 12588702
[TBL] [Abstract][Full Text] [Related]
4. RRR-alpha-tocopheryl succinate inhibits human prostate cancer cell invasiveness.
Zhang M; Altuwaijri S; Yeh S
Oncogene; 2004 Apr; 23(17):3080-8. PubMed ID: 15048090
[TBL] [Abstract][Full Text] [Related]
5. RRR-alpha-tocopheryl succinate enhances TGF-beta 1, -beta 2, and -beta 3 and TGF-beta R-II expression by human MDA-MB-435 breast cancer cells.
Charpentier A; Simmons-Menchaca M; Yu W; Zhao B; Qian M; Heim K; Sanders BG; Kline K
Nutr Cancer; 1996; 26(2):237-50. PubMed ID: 8875561
[TBL] [Abstract][Full Text] [Related]
6. Evidence for role of transforming growth factor-beta in RRR-alpha-tocopheryl succinate-induced apoptosis of human MDA-MB-435 breast cancer cells.
Yu W; Heim K; Qian M; Simmons-Menchaca M; Sanders BG; Kline K
Nutr Cancer; 1997; 27(3):267-78. PubMed ID: 9101557
[TBL] [Abstract][Full Text] [Related]
7. RRR-alpha-tocopheryl succinate inhibits proliferation and enhances secretion of transforming growth factor-beta (TGF-beta) by human breast cancer cells.
Charpentier A; Groves S; Simmons-Menchaca M; Turley J; Zhao B; Sanders BG; Kline K
Nutr Cancer; 1993; 19(3):225-39. PubMed ID: 8346072
[TBL] [Abstract][Full Text] [Related]
8. Modulation of murine EL-4 thymic lymphoma cell proliferation and cytokine production by vitamin E succinate.
Yu W; Sanders BG; Kline K
Nutr Cancer; 1996; 25(2):137-49. PubMed ID: 8710683
[TBL] [Abstract][Full Text] [Related]
9. Alpha-vitamin E derivative, RRR-alpha-tocopheryloxybutyric acid inhibits the proliferation of prostate cancer cells.
Chang E; Ni J; Yin Y; Lin CC; Chang P; James NS; Chemler SR; Yeh S
Asian J Androl; 2007 Jan; 9(1):31-9. PubMed ID: 17187157
[TBL] [Abstract][Full Text] [Related]
10. Differential response of human ovarian cancer cells to induction of apoptosis by vitamin E Succinate and vitamin E analogue, alpha-TEA.
Anderson K; Simmons-Menchaca M; Lawson KA; Atkinson J; Sanders BG; Kline K
Cancer Res; 2004 Jun; 64(12):4263-9. PubMed ID: 15205340
[TBL] [Abstract][Full Text] [Related]
11. Vitamin E succinate induces apoptosis in human prostate cancer cells: role for Fas in vitamin E succinate-triggered apoptosis.
Israel K; Yu W; Sanders BG; Kline K
Nutr Cancer; 2000; 36(1):90-100. PubMed ID: 10798221
[TBL] [Abstract][Full Text] [Related]
12. RRR-alpha-tocopheryl succinate inhibits EL4 thymic lymphoma cell growth by inducing apoptosis and DNA synthesis arrest.
Yu W; Sanders BG; Kline K
Nutr Cancer; 1997; 27(1):92-101. PubMed ID: 8970189
[TBL] [Abstract][Full Text] [Related]
13. The therapeutic and preventive effect of RRR-alpha-vitamin E succinate on prostate cancer via induction of insulin-like growth factor binding protein-3.
Yin Y; Ni J; Chen M; DiMaggio MA; Guo Y; Yeh S
Clin Cancer Res; 2007 Apr; 13(7):2271-80. PubMed ID: 17404112
[TBL] [Abstract][Full Text] [Related]
14. RRR-alpha-tocopheryl succinate inhibition of lectin-induced T cell proliferation.
Kline K; Sanders BG
Nutr Cancer; 1993; 19(3):241-52. PubMed ID: 8346073
[TBL] [Abstract][Full Text] [Related]
15. Vitamin E succinate inhibits NF-kappaB and prevents the development of a metastatic phenotype in prostate cancer cells: implications for chemoprevention.
Crispen PL; Uzzo RG; Golovine K; Makhov P; Pollack A; Horwitz EM; Greenberg RE; Kolenko VM
Prostate; 2007 May; 67(6):582-90. PubMed ID: 17262802
[TBL] [Abstract][Full Text] [Related]
16. 20-Cyclopropyl-cholecalciferol vitamin D3 analogs: a unique class of potent inhibitors of proliferation of human prostate, breast and myeloid leukemia cell lines.
Koike M; Koshizuka K; Kawabata H; Yang R; Taub HE; Said J; Uskokovic M; Tsuruoka N; Koeffler HP
Anticancer Res; 1999; 19(3A):1689-97. PubMed ID: 10470102
[TBL] [Abstract][Full Text] [Related]
17. Vitamin E succinate promotes breast cancer tumor dormancy.
Malafa MP; Neitzel LT
J Surg Res; 2000 Sep; 93(1):163-70. PubMed ID: 10945959
[TBL] [Abstract][Full Text] [Related]
18. Growth inhibition and apoptosis of RL human B lymphoma cells by vitamin E succinate and retinoic acid: role for transforming growth factor beta.
Turley JM; Funakoshi S; Ruscetti FW; Kasper J; Murphy WJ; Longo DL; Birchenall-Roberts MC
Cell Growth Differ; 1995 Jun; 6(6):655-63. PubMed ID: 7669719
[TBL] [Abstract][Full Text] [Related]
19. Tranilast inhibits hormone refractory prostate cancer cell proliferation and suppresses transforming growth factor beta1-associated osteoblastic changes.
Izumi K; Mizokami A; Li YQ; Narimoto K; Sugimoto K; Kadono Y; Kitagawa Y; Konaka H; Koh E; Keller ET; Namiki M
Prostate; 2009 Aug; 69(11):1222-34. PubMed ID: 19434660
[TBL] [Abstract][Full Text] [Related]
20. RRR-alpha-tocopheryl succinate induces MDA-MB-435 and MCF-7 human breast cancer cells to undergo differentiation.
You H; Yu W; Sanders BG; Kline K
Cell Growth Differ; 2001 Sep; 12(9):471-80. PubMed ID: 11571230
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
